Efficacy and Safety Trial to Evaluate the Sufentanil NanoTab® PCA System/15 mcg (Zalviso™) for Post-Operative Pain in Patients After Knee or Hip Replacement Surgery
Clinical trial NCT01660763 · COMPLETED
Trial details
- NCT number
- NCT01660763
- Sponsor
- Talphera, Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2013-04-01
- Enrollment
- 419
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.